Comparative Safety and Immunogenicity of VAX128A, VAC128B and VAX128C Novel H1N1 Influenza Vaccine in Healthy Adults

NCT01172054 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

292

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: VAX128
BIOLOGICAL: Placebo

Sponsor

VaxInnate Corporation